Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3770789019 | Varicella-zoster virus antibody only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3770790011 | Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Varicella-zoster virus antibody only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody only product in parenteral dose form | Is a | Varicella-zoster virus antibody only product | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody only product in parenteral dose form | Is a | Varicella-zoster virus antibody-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody only product in parenteral dose form | Has active ingredient | Antibody to Varicellovirus humanalpha3 (substance) | true | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody only product in parenteral dose form | Plays role | Passive immunity stimulant therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial | Is a | True | Varicella-zoster virus antibody only product in parenteral dose form | Inferred relationship | Some | |
| Varicella-zoster virus antibody 104 unit/mL solution for injection | Is a | True | Varicella-zoster virus antibody only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Varicella-zoster virus antibody only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR